🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsSide Effects & ManagementGLP-1 and gastroparesis — need advice Page 4

GLP-1 and gastroparesis — need advice

MounjBrad Sun, Mar 9, 2025 at 1:56 PM 38 replies 1,891 viewsPage 4 of 8
maya_sedona
Member
289
1,234
Sep 2024
Sedona, AZ
Mar 9, 2025 at 7:36 PM#16

Just wanted to say — for anyone reading this GLP-1 and gastropare thread who is feeling discouraged: it gets better. The first few weeks are the hardest. Hang in there. 💪

43 7wanda_boise, NurseAsh_DET, BenResearch_OR and 40 others
Reply Quote Save Share Report
fiona_VT
Member
178
890
Dec 2024
Vermont
Mar 9, 2025 at 7:53 PM#17

MounjBrad's experience with GLP-1 and gastroparesis resonates deeply with mine. I went through almost the identical process — starting dose, titration timeline, side effects, everything.

The main difference: I titrated faster. But the overall trajectory has been remarkably similar. Down 48 lbs in 13 months.

One thing I would add that MounjBrad did not mention: the relationship with food fundamentally changed.

Last edited: Mar 9, 2025 at 8:53 PM
35 4hans_munich, jason_sac26, chris_chi24 and 32 others
Reply Quote Save Share Report
sarah.morrison
VIP Member
3,212
14,567
Jan 2024
California
Online
Mar 9, 2025 at 8:10 PM#18

Saving this for reference. Quality thread.

Last edited: Mar 9, 2025 at 9:10 PM
47 3tony_orlando, Dr.NephBHM_UK, kim_atl_prep and 44 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
LindaRN_retired
Member
189
890
Dec 2024
Sarasota, FL
Mar 9, 2025 at 8:27 PM#19

As a healthcare provider, I want to add some clinical context to this discussion on GLP-1 and gastroparesis need advice.

Building on what MounjBrad said — the evidence base here is well-established. The key publications to reference are from the STEP program[1].

Key clinical points:

  1. Efficacy is dose-dependent and typically requires 4-5 weeks to reach steady state
  2. Side effect profile is predictable and usually manageable with standard protocols
  3. Monitoring should include baseline labs and follow-up at 3-month intervals
  4. Patient education significantly improves outcomes and adherence

Standard disclaimer: this is educational, not individualized medical advice.

References:
[1] See thread title for relevant study identification.
Last edited: Mar 9, 2025 at 11:27 PM
17 11LondonLisa, mike_nyc, VendorMark and 14 others
Reply Quote Save Share Report
PeptideSynthNJ
Member
234
1,234
Aug 2024
Princeton, NJ
Mar 9, 2025 at 8:44 PM#20

Subscribing to this thread. GLP-1 and gastroparesis is exactly what I've been researching. 🙏

8 16Dr.RaviCardio, jennifer_SEA, tyler_CSCS and 5 others
Reply Quote Save Share Report

Similar Threads

Nausea incidence by dose tier — STEP and SURMOUNT meta-analysis16 replies
Constipation on GLP-1: pathophysiology and fiber protocol5 replies
Alopecia on GLP-1 — telogen effluvium differential diagnosis3 replies
Gallbladder disease risk — cholelithiasis data from clinical trials12 replies
Pancreatitis risk assessment — pooled safety analysis15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register